Most Read Articles
Pearl Toh, 2 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
5 days ago
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.

Eating behaviour traits partly mediate genetic susceptibility to obesity

27 Sep 2018
One in five children worldwide are either obese or overweight.

It appears that undesirable eating behaviour (EB) traits play a part in mediating genetic susceptibility to obesity, according to a recent study, suggesting that EB traits can be targeted in obesity treatment and prevention.

This cross-sectional study included adult individuals (n=768) who participated in the Quebec Family Study. The authors calculated the genetic risk score (GRS) of obesity based on the 97 genetic variants recently identified in a genome-wide association studies (GWAS) meta-analysis of body mass index (BMI).

The Three-Factor Eating Questionnaire was used to assess EB traits and their subscales. Regression analyses with age and sex as covariates were conducted to examine the associations between GRS, EB traits, BMI and waist circumference (WC), and whether the association between GRS and obesity was mediated by EB traits, representing the indirect effect of GRS on obesity.

A positive association was found between GRS of obesity and BMI (β, 0.19±0.04; p<0.0001) and WC (β, 0.46±0.10; p<0.0001). Regression analyses also showed that disinhibition (βindirect, 0.09±0.03; p=0.0007) and susceptibility to hunger (βindirect, 0.04±0.02; p=0.02) partly mediated the association between GRS of obesity and BMI.

Habitual (βindirect, 0.08±0.03; p=0.002) and situational susceptibility (βindirect, 0.05±0.02; p=0.003) to disinhibition, as well as internal and external locus of hunger (βindirect, 0.03±0.02; p=0.03 for both), also mediated the association between GRS of obesity and BMI. The same trends were seen with WC.

“GWASs have identified several genes associated with obesity. The mechanisms through which these genes affect body weight are not fully characterized. Recent studies suggest that EB traits could be involved, but only a few EB traits were investigated,” the authors said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 2 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
5 days ago
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.